CuraGen Corporation operates as a biopharmaceutical development company in the United States. It develops novel protein, antibody, and small molecule therapeutics in the areas of oncology, inflammatory diseases, and diabetes. The company also commercializes advanced technologies for genetic analysis to perform comprehensive determination of the nucleotide sequence of genomes and ultra-deep sequencing of accurate detection of mutations in target genes of interest. Its products include velafermin, a protein for cancer supportive care; PXD101, a novel histone deacetylase inhibitor for the treatment of solid and hematologic cancers; CR011, a human monoclonal antibody stemming for the...
read more
QUOTE
As of 12:27PM EDT May 26, 2012
$
( )
Today's Open:
Today's Close:
| Today's High: |
|
Volume (thous): |
|
| Today's Low: |
|
Avg Vol (thous): |
|
| 52 Week High: |
|
Bid (size): |
|
| 52 Week Low: |
|
Ask (size): |
|
COMPANY INFO
To see the headquarters in Google Street View &trade, drag this yellow guy:
over to the red pointer:
Company Details:
| Symbol: |
CRGN |
| SIC: |
-
|
| State location: |
MA |
| Sector: |
- |
| State of Inc: |
DE |
| Employees: |
16 |
| Type: |
NASDAQ |
CURAGEN CORP (CRGN) MESSAGE BOARD
